PBE

Featured

5 Biotech ETFs If You’re Bullish

By Tom LydonJune 25, 2010

Featured

Biotech ETFs: Where the Future Lies

By Tom LydonFebruary 5, 2010

Featured

Biotechnology: Why ETFs Suit the Sector

By Tom LydonNovember 19, 2009

Featured

What Biotechnology ETFs Need to Thrive

By Tom LydonSeptember 4, 2009

Featured

7 Reasons Biotechnology ETFs Could Succeed

By Tom LydonAugust 6, 2009

Featured

ETF Spotlight: PowerShares Dynamic Biotech & Genome (PBE)

By Tom LydonJuly 29, 2009

Featured

Biotech Sector and ETFs Get a Lifeline

By Tom LydonJuly 8, 2009

Featured

Health Care Reform and Biotech ETFs: Will There Be Opportunities?

By Tom LydonJune 27, 2009

Featured

Why Biotech ETFs May Be the Better Choice

By Tom LydonJune 17, 2009

Featured

Can Obama’s Push Reignite Biotech and Health Care ETFs?

By Tom LydonJune 15, 2009

Featured

Health Care ETFs’ $140 Billion Boost

By Tom LydonFebruary 19, 2009

Alternative ETFs

PowerShares’ ETF Family Grows With Biotech, Commodities

By Tom LydonSeptember 18, 2008

Featured

Genentech Holds Out for Better Offer, Which Could Deliver a Boost to Biotech ETFs

By Tom LydonAugust 14, 2008

Featured

Biotech ETFs Are a Matter of Personal Choice

By Tom LydonJuly 27, 2008

Alternative ETFs

Biotechnology ETFs Growing…Like Genetically Modified Crops?

By Tom LydonJuly 16, 2008